Tigecycline (GAR-936) is a broad-spectrum glycylcycline antibiotic. It has been shown to inhibit AML2 and HL-60 cells, with specific IC50 values. Its activity extends to bacterial strains, demonstrating a mean inhibitory concentration (MIC) of approximately 125 ng/mL for E. coli (MG1655 strain), and MIC50 and MIC90 values of 1 and 2 mg/L, respectively, for Acinetobacter baumannii.
- Broad-spectrum glycylcycline antibiotic
- Inhibits AML2 and HL-60 cells in vitro
- Demonstrates activity against E. coli and Acinetobacter baumannii
- Light yellow to orange solid appearance
- Derived from microorganisms
- Reduced tumor volume and weight in an AML xenograft model